Neupane, B.; Pradhan, K.; Ortega-Ramirez, A.M.; Aidery, P.; Kucikas, V.; Marks, M.; van Zandvoort, M.A.M.J.; Klingel, K.; Witte, K.K.; Gründer, S.;
et al. Personalized Medicine Approach in a DCM Patient with LMNA Mutation Reveals Dysregulation of mTOR Signaling. J. Pers. Med. 2022, 12, 1149.
https://doi.org/10.3390/jpm12071149
AMA Style
Neupane B, Pradhan K, Ortega-Ramirez AM, Aidery P, Kucikas V, Marks M, van Zandvoort MAMJ, Klingel K, Witte KK, Gründer S,
et al. Personalized Medicine Approach in a DCM Patient with LMNA Mutation Reveals Dysregulation of mTOR Signaling. Journal of Personalized Medicine. 2022; 12(7):1149.
https://doi.org/10.3390/jpm12071149
Chicago/Turabian Style
Neupane, Balram, Kabita Pradhan, Audrey Magdalena Ortega-Ramirez, Parwez Aidery, Vytautas Kucikas, Matthias Marks, Marc A. M. J. van Zandvoort, Karin Klingel, Klaus K. Witte, Stefan Gründer,
and et al. 2022. "Personalized Medicine Approach in a DCM Patient with LMNA Mutation Reveals Dysregulation of mTOR Signaling" Journal of Personalized Medicine 12, no. 7: 1149.
https://doi.org/10.3390/jpm12071149
APA Style
Neupane, B., Pradhan, K., Ortega-Ramirez, A. M., Aidery, P., Kucikas, V., Marks, M., van Zandvoort, M. A. M. J., Klingel, K., Witte, K. K., Gründer, S., Marx, N., & Gramlich, M.
(2022). Personalized Medicine Approach in a DCM Patient with LMNA Mutation Reveals Dysregulation of mTOR Signaling. Journal of Personalized Medicine, 12(7), 1149.
https://doi.org/10.3390/jpm12071149